Evidence map›Paper›PMID 30974898›Full record

ReviewViruses2019

Norovirus Infections and Disease in Lower-MiddleandLow-Income Countries, 1997⁻2018.

Janet Mans

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Janet MansDepartment of Medical Virology, Faculty of Health Sciences, University of Pretoria,Pretoria 0001, South Africa. janet.mans@up.ac.za.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Noroviruses are a major cause of viral gastroenteritis. The burden of the norovirus in lowresourcesettings is not well-established due to limited data. This study reviews the norovirusprevalence, epidemiology, and genotype diversity in lower-middle-income countries (LMIC) andin low-income countries (LIC). PubMed was searched up to 14 January 2019 for norovirus studiesfrom all LIC and LMIC (World Bank Classification). Studies that tested gastroenteritis cases and/orasymptomatic controls for norovirus by reverse transcription-polymerase chain reaction (RT-PCR)were included. Sixty-four studies, the majority on children <5 years of age, were identified, and 14%(95% confidence interval; CI 14-15, 5158/36,288) of the gastroenteritis patients and 8% (95% CI 7-9,423/5310) of healthy controls tested positive for norovirus. In LMIC, norovirus was detected in 15%(95% CI 15-16) of cases and 8% (95% CI 8-10) of healthy controls. In LIC, 11% (95% CI 10-12) ofsymptomatic cases and 9% (95% CI 8-10) of asymptomatic controls were norovirus positive.Norovirus genogroup II predominated overall. GII.4 was the predominant genotype in all settings,followed by GII.3 and GII.6. The most prevalent GI strain was GI.3. Norovirus causes a significantamount of gastroenteritis in low-resource countries, albeit with high levels of asymptomaticinfection in LIC and a high prevalence of coinfections.

Indexed as

Developing CountriesCaliciviridae InfectionsCoinfectionGastroenteritisGenetic VariationGenotypeHumansNorovirusPrevalenceSeasonsgenotype diversityGII.4lower‐middle‐income countrieslow‐income countriesnorovirussystematic review

Identifiers

PMID30974898
PMCPMC6521228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.